FDA Proposes Replacing 'Animal' with 'Nonclinical' in Test Terminology

The FDA is proposing regulatory amendments to substitute 'nonclinical' for 'animal' and 'preclinical' in safety and reporting sections, aligning with recent statutory changes. This is a procedural terminology shift, not a substantive policy change, but signals a regulatory modernization trend. The impact is limited to regulatory language and does not alter testing requirements.